ATE503458T1 - Reverse mizellen auf basis von phytosterolen und acylglycerolen und therapeutischen verwendungen derselben - Google Patents

Reverse mizellen auf basis von phytosterolen und acylglycerolen und therapeutischen verwendungen derselben

Info

Publication number
ATE503458T1
ATE503458T1 AT05803808T AT05803808T ATE503458T1 AT E503458 T1 ATE503458 T1 AT E503458T1 AT 05803808 T AT05803808 T AT 05803808T AT 05803808 T AT05803808 T AT 05803808T AT E503458 T1 ATE503458 T1 AT E503458T1
Authority
AT
Austria
Prior art keywords
acylglycerols
phytosterols
therapeutic uses
reverse micellar
reverse
Prior art date
Application number
AT05803808T
Other languages
English (en)
Inventor
Jean-Claude Maurel
Original Assignee
Medesis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medesis Pharma Sa filed Critical Medesis Pharma Sa
Application granted granted Critical
Publication of ATE503458T1 publication Critical patent/ATE503458T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1816Erythropoietin [EPO]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT05803808T 2004-11-02 2005-11-02 Reverse mizellen auf basis von phytosterolen und acylglycerolen und therapeutischen verwendungen derselben ATE503458T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04025991A EP1652513A1 (de) 2004-11-02 2004-11-02 Reverse Mizellen auf der Basis von Sterolen und Acylglycerolen und ihre therapeutischen Verwendungen
PCT/IB2005/003592 WO2006048772A2 (en) 2004-11-02 2005-11-02 Reverse micelles based on phytosterols and acylglycerols and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
ATE503458T1 true ATE503458T1 (de) 2011-04-15

Family

ID=34927201

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05803808T ATE503458T1 (de) 2004-11-02 2005-11-02 Reverse mizellen auf basis von phytosterolen und acylglycerolen und therapeutischen verwendungen derselben

Country Status (17)

Country Link
US (1) US8637314B2 (de)
EP (2) EP1652513A1 (de)
JP (1) JP4954079B2 (de)
CN (1) CN101102747B (de)
AT (1) ATE503458T1 (de)
AU (1) AU2005300252B2 (de)
CA (1) CA2584980C (de)
DE (1) DE602005027231D1 (de)
DK (1) DK1807046T3 (de)
EA (1) EA012453B1 (de)
ES (1) ES2360809T3 (de)
HK (1) HK1108369A1 (de)
IL (1) IL182747A (de)
PL (1) PL1807046T3 (de)
PT (1) PT1807046E (de)
WO (1) WO2006048772A2 (de)
ZA (1) ZA200704285B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1652512A1 (de) * 2004-11-02 2006-05-03 Medesis Pharma Umkehrmizellen-Zusammensetzung zur Verabreichung von Metallkationen enthaltend einen Diglycerid und einen Phytosterol und Verfahren zur Herstellung
WO2011117333A2 (en) * 2010-03-24 2011-09-29 Medesis Pharma Reverse micelle system comprising metal ions and use thereof
WO2011117334A2 (en) * 2010-03-24 2011-09-29 Medesis Pharma Reverse micelle system comprising nucleic acids and use thereof
CN102940654A (zh) * 2012-10-12 2013-02-27 江苏大学 一种金针菇不皂化提取物甾醇的三元纳米胶束及其制备方法
CN103203192B (zh) * 2013-02-05 2015-08-12 东华大学 一种非离子反胶束体系及其改性极性物质的方法
EP3319588A1 (de) * 2015-07-09 2018-05-16 Medesis Pharma In-situ-herstellung von cyano-verbrückten metallnanopartikeln innerhalb eines biokompatiblen reversmizellaren systems
WO2017031392A1 (en) * 2015-08-20 2017-02-23 University Of Florida Research Foundation, Incorporated Lipid compounds for treatment of obesity, hypertension and metabolic syndrome
CN108822228A (zh) * 2018-06-28 2018-11-16 广东省农业科学院蚕业与农产品加工研究所 一种荔枝多糖的快速纯化方法
WO2023025899A2 (en) * 2021-08-26 2023-03-02 Transgene Delivery system for targeting genes of the interferon pathway

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
DE4038385C2 (de) * 1990-12-01 1998-09-17 Hoyer Gmbh & Co Kg Sitosterol und seine Glykoside mit verbesserter Bioverfügbarkeit
FR2729957B1 (fr) * 1995-01-31 1997-12-05 Maurel Sante Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant.
DE19539429C1 (de) * 1995-10-24 1997-04-24 Kawes S L Wasser/Öl-Misch-Emulgator sowie dessen Verwendung in kosmetischen und pharmazeutischen Salben, Cremes, Lotionen, Seifen, Shampoos und Badezusätzen
US5693516A (en) * 1995-11-27 1997-12-02 Novo Nordisk Biotech, Inc. Method for solubilizing proteins in organic solvents
FR2750606B1 (fr) * 1996-07-03 1999-01-29 Maurel Sante Complexes organometalliques a base de sitosterols et de diglycerides et compositions pharmaceutiques en contenant
WO2001015201A2 (en) * 1999-08-26 2001-03-01 University Of New Hampshire Multiple stage mass spectrometer
US6951655B2 (en) * 2001-10-11 2005-10-04 Imi Biomed, Inc. Pro-micelle pharmaceutical compositions
JP5100974B2 (ja) * 2004-04-28 2012-12-19 花王株式会社 油脂組成物
EP1652512A1 (de) * 2004-11-02 2006-05-03 Medesis Pharma Umkehrmizellen-Zusammensetzung zur Verabreichung von Metallkationen enthaltend einen Diglycerid und einen Phytosterol und Verfahren zur Herstellung

Also Published As

Publication number Publication date
CA2584980A1 (en) 2006-05-11
AU2005300252A1 (en) 2006-05-11
DE602005027231D1 (de) 2011-05-12
CN101102747B (zh) 2012-10-24
PL1807046T3 (pl) 2011-09-30
PT1807046E (pt) 2011-05-06
EP1652513A1 (de) 2006-05-03
US8637314B2 (en) 2014-01-28
CN101102747A (zh) 2008-01-09
IL182747A0 (en) 2007-07-24
EA200700993A1 (ru) 2007-10-26
EA012453B1 (ru) 2009-10-30
WO2006048772A2 (en) 2006-05-11
WO2006048772A3 (en) 2006-10-19
IL182747A (en) 2011-12-29
JP2008519025A (ja) 2008-06-05
US20090087406A1 (en) 2009-04-02
AU2005300252B2 (en) 2010-08-26
CA2584980C (en) 2014-01-07
JP4954079B2 (ja) 2012-06-13
DK1807046T3 (da) 2011-05-23
HK1108369A1 (en) 2008-05-09
ZA200704285B (en) 2009-04-29
EP1807046B1 (de) 2011-03-30
EP1807046A2 (de) 2007-07-18
ES2360809T3 (es) 2011-06-09

Similar Documents

Publication Publication Date Title
ATE503458T1 (de) Reverse mizellen auf basis von phytosterolen und acylglycerolen und therapeutischen verwendungen derselben
WO2008021088A3 (en) Salicylanilides enhance oral delivery of therapeutic peptides
MXPA05002814A (es) Formulacion para agentes lipofilicos.
DE60126923D1 (de) Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
BRPI0415858A (pt) compostos de medicamentos terapêuticos modificados por tocoferol
CY1109265T1 (el) Συνθεσεις που συμπεριλαμβανουν δροσπιρενονη μοριακα διασπαρμενη
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
NO20026255L (no) Polymere micellesammensetninger
ATE486840T1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
RS52199B (en) PHARMACEUTICAL COMPOSITIONS OF THE NEUROACTIVE STEROID AND THEIR USE
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
MA34832B1 (fr) Compositions biodegradables d'administration de medicaments
DE60216305D1 (de) Zusammensetzungen zur verabreichung von arzneimittelkombinationen
BRPI0414721A (pt) formulações estabilizadas de fosfatidilserina
CY1118930T1 (el) Ανασυνδυασμενες πρωτεϊνες ελαστασης και μεθοδοι βιομηχανικης κατασκευης και χρηση αυτων
DE50313292D1 (de) Vernebelbare liposomen und ihre verwendung zur pulmonalen applikation von wirkstoffen
ATE454385T1 (de) Hiv-integrase-hemmers, pharmazeutischen zusammensetzung und ihre anwendung
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
ATE521624T1 (de) Peptide und medizinische zusammensetzungen mit denselben
DZ3459A1 (fr) Derives de 2h-1-benzopyran, procedes de preparation de ces derniers et compositions pharmaceutiques dans lesquels ils entrent.
BRPI0510855A (pt) medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis
DE60225844D1 (de) Micelle-zusammensetzungen enthaltend pegylierten phospholipide und einen photosensibilisator
BRPI0401742A (pt) Composto análogo do ritonavir útil como inibidor de protease retroviral, preparação do composto análogo do ritonavir e composição farmacêutica do composto análogo do ritonavir
DE60235549D1 (de) Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1807046

Country of ref document: EP